Hims & Hers Health (HIMS) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free HIMS Stock Alerts $12.29 -0.63 (-4.88%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Hims & Hers Health Short Interest DataCurrent Short Volume18,390,000 sharesPrevious Short Volume17,470,000 sharesChange Vs. Previous Month+5.27%Dollar Volume Sold Short$230.24 millionShort Interest Ratio / Days to Cover3.0Last Record DateApril 30, 2024Outstanding Shares214,250,000 sharesFloat Size139,280,000 sharesShort Percent of Float13.20%Today's Trading Volume7,000,486 sharesAverage Trading Volume7,162,132 sharesToday's Volume Vs. Average98% Short Selling Hims & Hers Health ? Sign up to receive the latest short interest report for Hims & Hers Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHIMS Short Interest Over TimeHIMS Days to Cover Over TimeHIMS Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Hims & Hers Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202418,390,000 shares $230.24 million +5.3%13.2%3 $12.52 4/15/202417,470,000 shares $230.95 million +34.6%12.5%3.5 $13.22 3/31/202412,980,000 shares $200.80 million +1.7%9.4%2.8 $15.47 3/15/202412,760,000 shares $186.81 million +0.9%9.2%2.9 $14.64 2/29/202412,650,000 shares $164.96 million -6.1%9.1%3.1 $13.04 2/15/202413,470,000 shares $135.37 million -6.6%10.0%4.1 $10.05 Get the Latest News and Ratings for HIMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. 1/31/202414,420,000 shares $123.72 million -5.2%10.6%4.8 $8.58 1/15/202415,210,000 shares $130.35 million +1.1%11.2%5.3 $8.57 12/31/202315,040,000 shares $133.86 million -4.0%11.1%5.3 $8.90 12/15/202315,670,000 shares $132.33 million -7.9%11.5%6 $8.45 11/30/202317,020,000 shares $151.31 million -1.7%12.5%6.7 $8.89 11/15/202317,310,000 shares $133.63 million +2.1%12.8%7.2 $7.72 10/31/202316,960,000 shares $101.42 million -0.9%12.6%6.9 $5.98 10/15/202317,120,000 shares $107 million -3.0%12.7%6.7 $6.25 9/30/202317,640,000 shares $110.96 million +5.4%13.1%6.5 $6.29 9/15/202316,730,000 shares $105.57 million +0.5%12.4%5.9 $6.31 8/31/202316,650,000 shares $111.72 million -5.8%12.4%5.6 $6.71 8/15/202317,680,000 shares $127.03 million -21.4%13.1%5.4 $7.19 7/31/202322,480,000 shares $201.53 million -8.2%16.9%6.5 $8.97 7/15/202324,490,000 shares $216.98 million +10.9%18.4%7.7 $8.86 6/30/202322,090,000 shares $207.65 million +4.8%16.6%6.5 $9.40 6/15/202321,080,000 shares $185.50 million +3.9%15.8%6.2 $8.80 5/31/202320,280,000 shares $181.30 million -3.2%15.3%5.8 $8.94 5/15/202320,940,000 shares $225.52 million -7.0%17.0%5.4 $10.77 4/30/202322,510,000 shares $260.89 million -2.0%18.4%6.1 $11.59 4/15/202322,960,000 shares $224.09 million +2.5%18.9%6.7 $9.76 3/31/202322,410,000 shares $222.31 million +7.1%18.5%7.6 $9.92 3/15/202320,930,000 shares $188.58 million +9.8%17.3%8 $9.01 2/28/202319,060,000 shares $214.81 million +5.8%15.8%8.2 $11.27 2/15/202318,010,000 shares $180.64 million +4.4%15.9%10.5 $10.03 1/31/202317,260,000 shares $142.91 million +5.2%16.2%9.1 $8.28 1/15/202316,400,000 shares $123.49 million +1.5%15.4%9.5 $7.53 12/30/202216,160,000 shares $103.59 million No Change15.2%9.2 $6.41 12/15/202216,160,000 shares $111.50 million -1.8%15.2%9.2 $6.90 11/30/202216,460,000 shares $101.89 million +3.1%15.5%9.5 $6.19 11/15/202215,970,000 shares $98.85 million +21.2%15.1%9.4 $6.19 10/31/202213,180,000 shares $59.84 million -5.4%12.5%8.1 $4.54 10/15/202213,930,000 shares $66.45 million +6.5%13.2%8.9 $4.77 9/30/202213,080,000 shares $72.99 million -4.1%12.4%8.3 $5.58 9/15/202213,640,000 shares $82.25 million +2.3%12.9%7.1 $6.03Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. HIMS Short Interest - Frequently Asked Questions What is Hims & Hers Health's current short interest? Short interest is the volume of Hims & Hers Health shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 18,390,000 shares of HIMS short. 13.20% of Hims & Hers Health's shares are currently sold short. Learn More on Hims & Hers Health's current short interest. What is a good short interest ratio for Hims & Hers Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HIMS shares currently have a short interest ratio of 3.0. Learn More on Hims & Hers Health's short interest ratio. Which institutional investors are shorting Hims & Hers Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Hims & Hers Health: Simplex Trading LLC, and HAP Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Hims & Hers Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.20% of Hims & Hers Health's floating shares are currently sold short. Is Hims & Hers Health's short interest increasing or decreasing? Hims & Hers Health saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 18,390,000 shares, an increase of 5.3% from the previous total of 17,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hims & Hers Health's float size? Hims & Hers Health currently has issued a total of 214,250,000 shares. Some of Hims & Hers Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hims & Hers Health currently has a public float of 139,280,000 shares. How does Hims & Hers Health's short interest compare to its competitors? 13.20% of Hims & Hers Health's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Hims & Hers Health: Teladoc Health, Inc. (16.46%), TG Therapeutics, Inc. (27.08%), LifeStance Health Group, Inc. (22.44%), Neogen Co. (9.26%), MorphoSys AG (0.83%), Bausch Health Companies Inc. (5.73%), Corcept Therapeutics Incorporated (22.07%), Twist Bioscience Co. (20.49%), MoonLake Immunotherapeutics (14.00%), Arcellx, Inc. (8.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Hims & Hers Health stock? Short selling HIMS is an investing strategy that aims to generate trading profit from Hims & Hers Health as its price is falling. HIMS shares are trading down $0.63 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hims & Hers Health? A short squeeze for Hims & Hers Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HIMS, which in turn drives the price of the stock up even further. How often is Hims & Hers Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HIMS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Teladoc Health Short Interest Data TG Therapeutics Short Interest Data LifeStance Health Group Short Interest Data Neogen Short Interest Data MorphoSys Short Interest Data Bausch Health Companies Short Interest Data Corcept Therapeutics Short Interest Data Twist Bioscience Short Interest Data MoonLake Immunotherapeutics Short Interest Data Arcellx Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HIMS) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial Metals[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity